Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral.
DengueDiagnostic médical
#2
Quels tests pour le paludisme au Vietnam ?
Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme.
PaludismeTests de diagnostic
#3
Comment identifier la tuberculose ?
La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures.
TuberculoseDiagnostic médical
#4
Quels signes pour le choléra ?
Le choléra se diagnostique par des selles liquides et des tests de laboratoire.
CholéraDiagnostic médical
#5
Comment détecter une infection à VIH ?
Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH.
VIHDiagnostic médical
Symptômes
5
#1
Quels symptômes de la dengue ?
Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents.
DengueSymptômes
#2
Quels signes du paludisme ?
Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques.
PaludismeSymptômes
#3
Quels symptômes de la tuberculose ?
Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants.
TuberculoseSymptômes
#4
Quels signes du choléra ?
Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques.
CholéraSymptômes
#5
Quels symptômes d'une infection à VIH ?
Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés.
VIHSymptômes
Prévention
5
#1
Comment prévenir la dengue ?
Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques.
DenguePrévention
#2
Quelles mesures pour prévenir le paludisme ?
Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs.
PaludismePrévention
#3
Comment prévenir la tuberculose ?
Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention.
TuberculosePrévention
#4
Quelles précautions contre le choléra ?
Boire de l'eau potable, se laver les mains et consommer des aliments cuits.
CholéraPrévention
#5
Comment prévenir le VIH ?
Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH.
VIHPrévention
Traitements
5
#1
Quel traitement pour la dengue ?
Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate.
DengueTraitement
#2
Comment traiter le paludisme ?
Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme.
PaludismeTraitement
#3
Quel traitement pour la tuberculose ?
La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois.
TuberculoseTraitement
#4
Comment traiter le choléra ?
Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire.
CholéraTraitement
#5
Quel traitement pour le VIH ?
Le VIH est traité par des antirétroviraux pour contrôler la charge virale.
VIHTraitement
Complications
5
#1
Quelles complications de la dengue ?
Les complications incluent la dengue sévère, le choc et des hémorragies.
DengueComplications
#2
Quelles complications du paludisme ?
Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques.
PaludismeComplications
#3
Quelles complications de la tuberculose ?
Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments.
TuberculoseComplications
#4
Quelles complications du choléra ?
La déshydratation sévère peut entraîner un choc hypovolémique et la mort.
CholéraComplications
#5
Quelles complications du VIH ?
Le VIH peut mener à des infections opportunistes et à des cancers associés.
VIHComplications
Facteurs de risque
5
#1
Quels facteurs de risque pour la dengue ?
Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement.
DengueFacteurs de risque
#2
Quels facteurs de risque pour le paludisme ?
Vivre dans des zones endémiques, absence de protection contre les moustiques.
PaludismeFacteurs de risque
#3
Quels facteurs de risque pour la tuberculose ?
Conditions de vie précaires, immunodépression et contact avec des malades.
TuberculoseFacteurs de risque
#4
Quels facteurs de risque pour le choléra ?
Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés.
CholéraFacteurs de risque
#5
Quels facteurs de risque pour le VIH ?
Relations sexuelles non protégées, partage de seringues et absence de dépistage.
VIHFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vietnam : Questions médicales les plus fréquentes",
"headline": "Vietnam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vietnam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vietnam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Asie du Sud-Est",
"url": "https://questionsmedicales.fr/mesh/D001210",
"about": {
"@type": "MedicalCondition",
"name": "Asie du Sud-Est",
"code": {
"@type": "MedicalCode",
"code": "D001210",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vietnam",
"alternateName": "Vietnam",
"code": {
"@type": "MedicalCode",
"code": "D014744",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pham Quang Thai",
"url": "https://questionsmedicales.fr/author/Pham%20Quang%20Thai",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam."
}
},
{
"@type": "Person",
"name": "Le Van Tan",
"url": "https://questionsmedicales.fr/author/Le%20Van%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam."
}
},
{
"@type": "Person",
"name": "Marc Choisy",
"url": "https://questionsmedicales.fr/author/Marc%20Choisy",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "H Rogier van Doorn",
"url": "https://questionsmedicales.fr/author/H%20Rogier%20van%20Doorn",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "H T Nguyen",
"url": "https://questionsmedicales.fr/author/H%20T%20Nguyen",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Behavioral activation for smoking cessation and the prevention of smoking cessation-related weight gain: A randomized trial.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36739753",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.drugalcdep.2023.109792"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of Smoking Prevention Programs on the Knowledge, Attitudes, and Anti-Smoking Exposure Self-Efficacy among Non-Smoking Rural Seventh-Grade Students in Taiwan.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35955124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19159767"
}
},
{
"@type": "ScholarlyArticle",
"name": "Postpartum Behavioral Sleep Intervention for Smoking Relapse Prevention: A Pilot Trial.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36625953",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10995-022-03575-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "The STOP Program: a Hybrid Smoking Prevention and Cessation Training for Cancer Care Providers in Colombia and Peru.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37368119",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13187-023-02322-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "From a teacher and school leader perspective: What happened with smoking rules and practices during a three-year smoking preventive intervention? - Findings from the X:IT II study.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36645953",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.evalprogplan.2023.102236"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Asie",
"item": "https://questionsmedicales.fr/mesh/D001208"
},
{
"@type": "ListItem",
"position": 4,
"name": "Asie du Sud-Est",
"item": "https://questionsmedicales.fr/mesh/D001210"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vietnam",
"item": "https://questionsmedicales.fr/mesh/D014744"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vietnam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vietnam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vietnam",
"description": "Comment diagnostiquer la dengue au Vietnam ?\nQuels tests pour le paludisme au Vietnam ?\nComment identifier la tuberculose ?\nQuels signes pour le choléra ?\nComment détecter une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Smoking+Prevention#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vietnam",
"description": "Quels symptômes de la dengue ?\nQuels signes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du choléra ?\nQuels symptômes d'une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Smoking+Prevention#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vietnam",
"description": "Comment prévenir la dengue ?\nQuelles mesures pour prévenir le paludisme ?\nComment prévenir la tuberculose ?\nQuelles précautions contre le choléra ?\nComment prévenir le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Smoking+Prevention#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vietnam",
"description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la tuberculose ?\nComment traiter le choléra ?\nQuel traitement pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Smoking+Prevention#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vietnam",
"description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du choléra ?\nQuelles complications du VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Smoking+Prevention#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vietnam",
"description": "Quels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le choléra ?\nQuels facteurs de risque pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Smoking+Prevention#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la dengue au Vietnam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral."
}
},
{
"@type": "Question",
"name": "Quels tests pour le paludisme au Vietnam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme."
}
},
{
"@type": "Question",
"name": "Comment identifier la tuberculose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures."
}
},
{
"@type": "Question",
"name": "Quels signes pour le choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se diagnostique par des selles liquides et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Comment détecter une infection à VIH ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la dengue ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels signes du paludisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la tuberculose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes du choléra ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection à VIH ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir le paludisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Quelles précautions contre le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire de l'eau potable, se laver les mains et consommer des aliments cuits."
}
},
{
"@type": "Question",
"name": "Comment prévenir le VIH ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter le paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois."
}
},
{
"@type": "Question",
"name": "Comment traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le VIH ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH est traité par des antirétroviraux pour contrôler la charge virale."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, le choc et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation sévère peut entraîner un choc hypovolémique et la mort."
}
},
{
"@type": "Question",
"name": "Quelles complications du VIH ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH peut mener à des infections opportunistes et à des cancers associés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le paludisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones endémiques, absence de protection contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conditions de vie précaires, immunodépression et contact avec des malades."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choléra ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le VIH ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Relations sexuelles non protégées, partage de seringues et absence de dépistage."
}
}
]
}
]
}
National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam.
School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia; PathWest Laboratory Medicine, Department of Microbiology, Nedlands, WA, Australia. Electronic address: thomas.riley@uwa.edu.au.
Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Post-cessation weight gain (PCWG) is an obstacle to smoking cessation. This trial evaluated a behavioral intervention targeting alternative rewards to smoking and high calorie snacking to promote smok...
Adult smokers (n = 288; 119 females, 169 males) received eight weeks of transdermal nicotine and were randomized to eight sessions of behavioral activation for smoking cessation and the mitigation of ...
BAS+ and SC did not differ in smoking abstinence rates at the 26-week follow-up (OR=0.80, 95%CI 0.50-1.27, p = 0.34; 18% versus 23%). There were no significant differences in PCWG between BAS+ and SC ...
The results do not support the efficacy of BAS+ for smoking cessation and the prevention of PCWG. These findings join a growing body of research highlighting the challenge of minimizing PCWG and promo...
The disproportionate smoking prevalence among adolescents in rural Taiwan may be attributed to insufficient anti-smoking education. Increasing access to such education may help reduce initiation and p...
Rates of postpartum smoking relapse are high (70-90%) but standard relapse prevention interventions are not effective postpartum. This pilot study evaluated effects of a combined relapse prevention an...
Twenty-eight postpartum mothers were assigned to the intervention group-combined relapse prevention and behavioral sleep intervention-or to the comparison group-relapse prevention alone. Questionnaire...
The sleep intervention lengthened maternal nighttime actigraphic sleep by an average of 48 minutes nightly; lengthened the longest bout of consolidated actigraphic sleep by an average of 42 minutes ni...
(1) Postpartum sleep can be improved with behavioral interventions in women with a history of smoking. (2) Social-emotional postpartum support is an important factor in preventing smoking relapse for ...
We designed and tested the feasibility of the Smoking Cessation Training Program for Oncology Practice (STOP), a hybrid (face-to-face plus web-based) educational intervention to enhance Spanish-speaki...
School-based smoking preventive interventions are most effective if they consist of multiple components; one of them being strict anti-smoking rules, i.e., no smoking by anyone at any location during ...
We used data from 46 Danish schools that were enrolled in the evaluation of the X:IT II study - a smoking preventive intervention with three main components: one of them being strict anti-smoking rule...
Over time, student smoking rules got stricter; from three out of four at baseline to almost all schools having rules about no student smoking during school hours three years later. Employee smoking ru...
Although implementing and enforcing new rules in a school setting may be difficult, it seemed that most schools in the X:IT II study changed their rules and smoking practices for both students and emp...
We know little about how smoking prevention interventions might leverage social network structures to enhance protective social norms. In this study we combined statistical and network science methods...
Smoking initiation is concentrated among young people which strongly influences future smoking prevalence. This study aimed to investigate the prevalence of smoking and other tobacco product use and p...
it is needed the innovative interventions to promote smoking cessation behavior. This research analyzed the influence of comic as the communication media to the knowledge and attitude of the responden...
this research measured the knowledge and attitude of the respondent after they have been given comic as the educational media. It also explored the information about smoking status and social context ...
the mean score of knowledge between the respondents who had trained was higher than respondents who had no trained was significantly different (p<0.05). There was also significantly different of the m...
the comic is more effective as an educational media for non-smoker adolescents, adolescents who have not smoker family, and health educated adolescent....
Implementing the 2009 US Tobacco Control Act established a new infrastructure for tobacco and nicotine science. At its heart is the Food and Drug Administration (FDA) Center for Tobacco Products (CTP)...
This study aims to examine the effectiveness of the Self-Help Group (SHG) intervention in smoking prevention among adolescents....
This study was carried out in 2 Junior High Schools in Aceh Besar using a quasi-experimental method, which was conducted in the intervention and the control groups with a pre-post design. The number o...
The results of statistical tests using the Mann-Whitney and t-test showed that there was an effect of the SHG intervention on knowledge (p-value 0.043), attitude (p-value 0.001), intention (p-value 0....
Health practitioners, specifically community nurses are suggested to implement SHG interventions as one of the strategies for preventing smoking among adolescents....